BSEAstonea Labs LtdHighPositive
Announced Tue, 31 Mar · 18:50 IST

Acquisition of Equity Stake in Damaira Pharmaceuticals Private Limited

Listed Co AcquisitionStrategic Transactions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹159.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+3.8+0.6+0.6+49.7
Up moveDown movePending
AI summary

Astonea Labs Ltd has announced the acquisition of an equity stake in Damaira Pharmaceuticals Private Limited, as per a BSE corporate filing. The full details of the filing (such as stake percentage, deal value, and consideration) were not accessible because the BSE page containing the announcement was unavailable (page moved/error). No further specifics on the size of the acquisition, regulatory triggers, or financial impact could be verified from the source.

Likely market impact

Without confirmed deal size or stake details, the near-term impact on shareholders is unclear. Investors should wait for the full filing details (consideration, stake %, and whether SEBI open-offer thresholds are triggered) before drawing conclusions about earnings accretion or dilution.